Literature DB >> 19249081

Second neoplasms in survivors of endometrial cancer: impact of radiation therapy.

Sanjeev Kumar1, Jay P Shah, Christopher S Bryant, Awoniyi O Awonuga, Anthony N Imudia, Julie J Ruterbusch, Michele L Cote, Rouba Ali-Fehmi, Robert T Morris, John M Malone.   

Abstract

OBJECTIVE: To evaluate the association of radiotherapy to subsequent second cancers in endometrial carcinoma survivors.
METHODS: Subjects with endometrial cancer as their first malignancy were identified from the Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2004 and were divided into radiation (R) and No Radiation (NR) groups. Person years at risk (PYR), observed (O) and expected (E) counts and SIR (standardized incidence ratio) were determined. (%) increase in relative risk (RR) for R vs. NR group was calculated using Poisson regression. Absolute Excess Risk (AER) was 'O' minus 'E' per 10,000 PYRs.
RESULTS: Of 90,502 subjects 31,643 (34.9%) were in R and 52,182 (57.6%) in NR. The radiation status of 6677 (7.3%) was unknown. In the R group 4203 developed second cancers vs. 5563 in NR group; relative risk for R group-1.25 (95% CI 1.20 to 1.29). A total of 17.11 excess tumors were observed in R group (AER). The relative risk increased with latency of exposure and peaked at (>10 years), being 40% (p<0.001). The statistically significant (%) increase in RR for individual organs was as follows: urinary bladder (124%), vagina (88%), vulva (83%), sarcoma (70%), colon and rectum (43%) and lung (29%).
CONCLUSION: In the largest study reporting on association of radiotherapy to subsequent second neoplasms in endometrial cancer survivors, the increased risk of second cancers was most pronounced in the field of exposure and was affected by latency since exposure.

Entities:  

Mesh:

Year:  2009        PMID: 19249081     DOI: 10.1016/j.ygyno.2008.12.039

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Second malignancies in high‑dose areas of previous tumor radiotherapy.

Authors:  Birgitta Welte; Peter Suhr; Dirk Bottke; Detlef Bartkowiak; Wolfgang Dörr; Klaus Rüdiger Trott; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  [No increased rate of secondary malignancies after pelvic radiotherapy].

Authors:  Karen Huber; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2015-04       Impact factor: 3.621

3.  Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.

Authors:  Stefan Lönn; Ethel S Gilbert; Elaine Ron; Susan A Smith; Marilyn Stovall; Rochelle E Curtis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

Review 4.  Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America.

Authors:  Tracy Spinks; Heidi W Albright; Thomas W Feeley; Ron Walters; Thomas W Burke; Thomas Aloia; Eduardo Bruera; Aman Buzdar; Lewis Foxhall; David Hui; Barbara Summers; Alma Rodriguez; Raymond Dubois; Kenneth I Shine
Journal:  Cancer       Date:  2011-11-01       Impact factor: 6.860

5.  Is adjuvant radiotherapy necessary for FIGO stage 1a grade 2 endometrial endometrioid adenocarcinoma?

Authors:  Abdurrahman Hamdi İnan; Gülçin Şahin Ersoy; Yusuf Yıldırım; Tutku Gürbüz; Ayşe Gül Kebapçılar; Merih Hanhan
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-07-14

Review 6.  Adjuvant radiotherapy for stage I endometrial cancer.

Authors:  Anthony Kong; Nick Johnson; Henry C Kitchener; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

7.  Detailed methods of two home-based vegetable gardening intervention trials to improve diet, physical activity, and quality of life in two different populations of cancer survivors.

Authors:  Mallory G Cases; Andrew D Frugé; Jennifer F De Los Santos; Julie L Locher; Alan B Cantor; Kerry P Smith; Tony A Glover; Harvey J Cohen; Michael Daniel; Casey D Morrow; Douglas R Moellering; Wendy Demark-Wahnefried
Journal:  Contemp Clin Trials       Date:  2016-08-23       Impact factor: 2.226

Review 8.  American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.

Authors:  Matthew M Harkenrider; Alec M Block; Kaled M Alektiar; David K Gaffney; Ellen Jones; Ann Klopp; Akila N Viswanathan; William Small
Journal:  Brachytherapy       Date:  2016-05-31       Impact factor: 2.362

9.  Multiple synchronous primary neoplasms of the breast, colon and rectum after surgery for endometrial cancer: A case report.

Authors:  Charalampos Markakis; Athanasios Marinis; Panagiotis Dikeakos; Paraskevas Grivas; Mavroudis Voultsos; Emmanouil Liarmakopoulos; Patritsia Zervogiannakou; Spyridon Rizos
Journal:  Int J Surg Case Rep       Date:  2013-01-17

10.  The effect of postoperative beam, implant, and combination radiation therapy on GI and bladder toxicities in female Medicare beneficiaries with stage I uterine cancer.

Authors:  Rafael Samper-Ternent; Humera Asem; Dong D Zhang; Yong-Fang Kuo; Sandra S Hatch; Jean L Freeman; Abbey B Berenson
Journal:  J Geriatr Oncol       Date:  2012-07-18       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.